Résultats: 15

    Prevention, diagnosis, and treatment of VTE in patients with Coronavirus Disease 2019: CHEST guideline and expert panel report

    Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of...

    COVID-19 rapid guideline: interstitial lung disease

    The purpose of this guideline is to maximise the safety of adults with interstitial lung disease, including idiopathic pulmonary fibrosis and pulmonary sarcoidosis, during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....

    COVID-19 rapid guideline: acute kidney injury in hospital (NG175)

    The purpose of this guideline is to help healthcare professionals prevent, detect and manage acute kidney injury in adults in hospital with known or suspected COVID-19. This is important to improve outcomes and reduce the need for renal replacement therapy....

    COVID-19 rapid guideline: children and young people who are immunocompromised

    The purpose of this guideline is to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....

    COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

    The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID 19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resource...

    COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response

    The purpose of this guideline is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....

    COVID-19 rapid guideline: cystic fibrosis

    The purpose of this guideline is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic....

    Guidelines for critical care of seriously ill adult patients with Coronavirus (COVID-19) in the Americas: short version

    This clinical practice guideline provides evidence-informed recommendations for infection control, specimen collection, supportive care, pharmacological treatment, and prevention of complications. The recommendations are directed to all health care staff who deal with patients in emergency departments an...

    Guía para el cuidado crítico de pacientes adultos graves con Coronavirus (COVID-19) en las Américas: versión larga

    Esta guía de práctica clínica provee recomendaciones informadas en la evidencia para el control de la infección, recolección de muestras, cuidado de soporte, tratamiento farmacológico y prevención de complicaciones. Las recomendaciones están dirigidas a todo el personal de salud que atiende a los...

    COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders

    The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources....